For: | Zuo MX, An C, Cao YZ, Pan JY, Xie LP, Yang XJ, Li W, Wu PH. Camrelizumab, apatinib and hepatic artery infusion chemotherapy combined with microwave ablation for advanced hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(8): 3481-3495 [PMID: 39171171 DOI: 10.4251/wjgo.v16.i8.3481] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v16/i8/3481.htm |
Number | Citing Articles |
1 |
Rui Huang, Jing Cui. Impact of Linggui Zhugan decoction on microwave ablation outcomes and recurrence in liver cancer. World Journal of Gastrointestinal Oncology 2025; 17(2): 101177 doi: 10.4251/wjgo.v17.i2.101177
|
2 |
Ali Gawi Ermi, Devanand Sarkar. Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance. Cancers 2024; 16(23): 3944 doi: 10.3390/cancers16233944
|
3 |
Fei-Yu Zhao, Guo-Wei Si, Nian-Song Qian. TRIPLET combined with microwave ablation: A novel treatment for advanced hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2025; 17(1): 98572 doi: 10.4251/wjgo.v17.i1.98572
|